7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          DNA interstrand crosslinks (ICLs), highly toxic lesions that covalently link the Watson and Crick strands of the double helix, are repaired by a complex, replication-coupled pathway in higher eukaryotes. The earliest DNA processing event in ICL repair is the incision of parental DNA on either side of the ICL (“unhooking”), which allows lesion bypass. Incisions depend critically on the Fanconi anemia pathway, whose activation involves ubiquitylation of the FANCD2 protein. Using Xenopus egg extracts, which support replication-coupled ICL repair, we show that the 3′ flap endonuclease XPF-ERCC1 cooperates with SLX4/FANCP to carry out the unhooking incisions. Efficient recruitment of XPF-ERCC1 and SLX4 to the ICL depends on FANCD2 and its ubiquitylation. These data help define the molecular mechanism by which the Fanconi anemia pathway promotes a key event in replication-coupled ICL repair.

          Related collections

          Author and article information

          Journal
          9802571
          20730
          Mol Cell
          Mol. Cell
          Molecular cell
          1097-2765
          1097-4164
          11 October 2016
          10 April 2014
          8 May 2014
          17 October 2016
          : 54
          : 3
          : 460-471
          Affiliations
          [1 ]Hubrecht Institute-KNAW, University Medical Center Utrecht & Cancer GenomiCs Netherlands, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
          [2 ]Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA
          [3 ]Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
          Author notes
          [4]

          These authors contributed equally to this work

          Article
          PMC5067070 PMC5067070 5067070 nihpa812569
          10.1016/j.molcel.2014.03.015
          5067070
          24726325
          e8136730-b428-4bdb-b41c-7572f2ff20a4
          History
          Categories
          Article

          Comments

          Comment on this article